TGF-β Suppresses IFN-γ Induction of Class II MHC Gene Expression by Inhibiting Class II Transactivator Messenger RNA Expression

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2065-2075

  Lee, Yi Ju ^a   Han, Yulong ^b   Lu, Hong Tao ^b   Nguyen, Vincent ^a   Qin, Hongwei ^a   Howe, Philip H ^b   Hocevar, Barbara A ^b   Boss, Jeremy M ^c   Ransohoff, Richard M ^b   Benveniste, Etty N ^a,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TETRACYCLINE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ASTROCYTOMA; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; FIBROSARCOMA; GENE; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; HUMAN; IMMUNOLOGY; SIGNAL TRANSDUCTION;

ASTROCYTOMA; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; GENES, MHC CLASS II; HUMANS; INTERFERON TYPE II; NUCLEAR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRACYCLINE; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031093495     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Benacerraf, B. 1981. Role of MHC gene products in immune regulation. Science 212:1229.
2. Rothenberg, E. V. 1994. Signaling mechanisms in thymocyte selection. Curr. Opin. Immunol. 6:257.
3. Rohn, W. M., Y.-J. Lee, and E. N. Benveniste. 1996. Regulation of class II MHC expression. Crit. Rev. Immunol. 16:311.
4. Grusby, M. J., and L. H. Glimcher. 1995. Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13:417.
5. Mach, B., V. Steimle, and W. Reith. 1994. MHC class II-deficient combined immunodeficiency: a disease of gene regulation. Immunol. Rev. 138:207.
6. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
7. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class II transcription. Annu. Rev. Immunol. 10:13.
8. Ting, J. P.-Y., and A. S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8.
9. Abdulkadir, S. A., and S. J. Ono. 1995. How are class II MHC genes turned on and off? FASEB J. 9:1429.
10. Reith, W., C.-A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
11. Reith, W., M. Kobr, P. Emery, B. Durand, C.-A. Siegrist, and B. Mach. 1994. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269:20020.
12. Riley, J. L., and J. M. Boss. 1993. Class II MHC transcriptional mutants are defective in higher order complex formation. J. Immunol. 151:6942.
13. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
14. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
15. Chang, C.-H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
16. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
17. Lee, Y.-J., and E. N. Benveniste. 1996. STAT-1α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes. J. Immunol. 157:7559.
18. Chang, C.-H., S. Guerder, S.-C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
19. Suzumura, A., M. Sawada, H. Yamamoto, and T. Marunouchi. 1993. Transforming growth factor-β suppresses activation and proliferation of microglia in vitro. J. Immunol. 151:2150.
20. Zuber, P., M. C. Kuppner, and N. de Tribolet. 1988. Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur. J. Immunol. 18:1623.
21. 1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140:4217.
22. 1 repression of the HLA-DRα gene is mediated by conserved proximal promoter elements. J. Immunol. 151:4173.
23. Panek, R. B., Y.-J. Lee, and E. N. Benveniste. 1995. TGF-β suppression of IFN-γ induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2 or STAT1α or modification of IFNEX expression. J. Immunol. 154:610.
24. Ling, P. D., M. K. Warren, and S. N. Vogel. 1985. Antagonistic effect of interferon-β on the interferon-γ-induced expression of Ia antigen in murine macrophages. J. Immunol. 135:1857.
25. Devajyothi, C., I. Kalvakolanu, G. T. Babcock, H. A. Vasavada, P. H. Howe, and R. M. Ransohoff. 1993. Inhibition of interferon-γ-induced major histocompatibility complex class II gene transcription by interferon-β and type β1 transforming growth factor in human astrocytoma cells: definition of cis-element. J. Biol. Chem. 268:18794.
26. de Waal Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
27. Frei, K., H. Lins, C. Schwerdel, and A. Fontana. 1994. Antigen presentation in the central nervous system: the inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152:2720.
28. Massague, J. 1990. The transforming growth factor-β family. Annu. Rev. Cell. Biol. 6:597.
29. Benveniste, E. N., J. B. Kwon, W. J. Chung, J. Sampson, K. Pandya, and L.-P. Tang. 1994. Differential modulation of astrocyte cytokine gene expression by TGF-β. J. Immunol. 153:5210.
30. Shrikant, P., S. J. Lee, I. Kalvakalanu, R. M. Ransohoff, and E. N. Benveniste. 1996. Stimulus-specific inhibition of ICAM-1 gene expression by TGF-β. J. Immunol. 157:892.
31. Gamble, J. R., S. Bradley, L. Noack, and M. A. Vadas. 1995. TGF-β and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 15:949.
32. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693.
33. 1 null mouse phenotype. Proc. Natl. Acad. Sci. USA 90:9944.
34. Rosenman, S. J., P. Shrikant, L. Dubb, E. N. Benveniste, and R. M. Ransohoff. 1995. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154:1888.
35. Pellegrini, S., J. John, M. Shearer, I. M. Kerr, and G. R. Stark. 1989. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9:4605.
36. Lu, H.-T., J. L. Riley, G. T. Babcock, M. Huston, G. R. Stark, J. M. Boss, and R. M. Ransohoff. 1995. Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-γ. J. Exp. Med. 182:1517.
37. Riley, I. L., S. D. Westerheide, J. A. Price, J. A. Brown, and I. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
38. Hocevar, B. A., and P. H. Howe. 1996. Isolation and characterization of mutant cell lines defective in transforming growth factor β signaling. Proc. Natl. Acad. Sci. USA 93:7655.
39. + entry. J. Biol. Chem. 266:18119.
40. Shrikant, P., D. J. Benos, L.-P. Tang, and E. N. Benveniste. 1996. HIV gp120 enhances ICAM-1 gene expression in glial cells: involvement of JAK/STAT and protein kinase C signaling pathways. J. Immunol. 156:1307.
41. Lee, Y.-J., R. B. Panek, M. Huston, and E. N. Benveniste. 1995. Role of protein kinase C and tyrosine kinase activity in IFN-γ induced expression of the class II MHC gene. Am. J. Physiol. Cell Physiol. 37:127.
42. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
43. Vidovic, M., S. M. Sparacio, M. Elovitz, and E. N. Benveniste. 1990. Induction and regulation of class II MHC mRNA expression in astrocytes by IFN-γ and TNF-α. J. Neuroimmunol. 30:189.
44. Panek, R. B., H. Moses, J. P.-Y. Ting, and E. N. Benveniste. 1992. Tumor necrosis factor α response elements in the HLA-DRA promoter: identification of a tumor necrosis factor α-induced DNA-protein complex in astrocytes. Proc. Natl. Acad. Sci. USA 89:11518.
45. Schluesener, H. J. 1990. Transforming growth factors type β1 and β2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-γ and tumor necrosis factor-α. J. Neuroimmunol. 27:41.
46. 1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures. Brain Res. 585:229.
47. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
48. Westerhausen, D. R., Jr., W. E. Hopkins, and J. J. Billadello. 1991. Multiple transforming growth factor-β-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells. J. Biol. Chem. 266:1092.
49. Riccio, A., P. V. Pedone, L. R. Lund, T. Olesen, H. S. Olsen, and P. A. Andreasen. 1992. Transforming growth factor β1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene. Mol. Cell. Biol. 12:1846.
50. Laiho, M., O. Saksela, P. A. Andreasen, and J. Keski-Oja. 1986. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J. Cell Biol. 103:2403.
51. Figueiredo, F., R. J. Uhing, K. Okonogi, T. W. Gettys, S. P. Johnson, D. O. Adams, and V. Prpic. 1990. Activation of the cAMP cascade inhibits an early event involved in murine macrophage Ia expression. J. Biol. Chem. 265:12317.
52. Ivashkiv, L. B., and L. H. Glimcher. 1991. Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements. J. Exp. Med. 174:1583.
53. Sicher, S. C., M. A. Vazquez, and C. Y. Lu. 1994. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1293.
54. Celada, A., S. McKercher, and R. A. Maki. 1993. Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein. J. Exp. Med. 177:691.
55. Kerr, L. D., D. B. Miller, and L. M. Matrisian. 1990. TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 61:267.
56. Meraz, M., J. M. White, K. C. F. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
57. Chang, C.-H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765.
58. Pazdrak, K., L. Justement, and R. Alam. 1995. Mechanism of inhibition of eosinophil activation by transforming growth factor-β. J. Immunol. 155:4454.
59. Sriram, S., L. Kerr, and J. Bright. 1996. TGFβ2 regulates the IL2 and IL12 induced Jak-Stat pathway in T cells. FASEB J. 10:A1303.
60. Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. 1994. Mechanism of activation of the TGF-β receptor. Nature 370:341.
61. ten Dijke, P. T., K. Miyazono, and C.-H. Heldin. 1996. Signaling via heterooligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol. 8:139.
62. Huwiler, A., and J. Pfeilschifter. 1994. Transforming growth factor β2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells. FEBS Lett. 354:255.
63. Robertson, P. L., J. Markovac, S. C. Datta, and G. W. Goldstein. 1988. Transforming growth factor beta stimulates phosphoinositol metabolism and translocation of protein kinase C in cultured astrocytes. Neurosci. Lett. 93:107.
64. Halstead, J., K. Kemp, and R. A. Ignotz. 1995. Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth factor-β signaling. J. Biol. Chem. 270:13600.
65. Yamaguchi, K., K. Shirakabe, H. Shibuya, K. Irie, I. Oishi, N. Ueno, T. Taniguchi, E. Nishida, and K. Matsumoto. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008.
66. 1 that require Giα1. J. Biol. Chem. 268:19851.